abstract |
The present invention relates to cathepsin K inhibitors and uses thereof; specifically, the present invention relates to a class of compounds and pharmaceutical compositions thereof for treating or preventing cathepsin-dependent disorders, and these compounds and compositions comprising these compounds can be used as Bone resorption inhibitors to treat related diseases. Wherein, the cathepsin includes but not limited to cathepsin K. |